K. Ramskogler

发表

BIOMARKER: Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma‐glutamyl transpeptidase, mean corpuscular volume and carbohydrate‐deficient transferrin

F. Wurst, S. Hartmann, C. Alling, 2007, Addiction biology.

Subgroups of Alcohol Dependence and their Specific Therapeutic Management: A Review and Introduction to the Lesch- Typology Ramskogler K, Walter H, Hertling I, Riegler A, Gutierrez K, Lesch OM Correspondence:

K. Ramskogler, O. Lesch, H. Walter, 2006 .

Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

K. Ramskogler, O. Lesch, D. Hartl, 2006, Wiener Medizinische Wochenschrift.

The European acamprosate trials: conclusions for research and therapy.

K. Ramskogler, O. Lesch, H. Walter, 2001, Journal of biomedical science.

Gender-specific differences in alcoholism: Implications for treatment

K. Ramskogler, O. Lesch, H. Walter, 2003, Archives of Women’s Mental Health.

Craving and other characteristics of the comorbidity of alcohol and nicotine dependence

G. Saletu-Zyhlarz, M. Kunze, K. Ramskogler, 2005, European Psychiatry.

The Austrian Multicentre Study on Smoking: Subgroups of Nicotine Dependence and Their Craving

G. Saletu-Zyhlarz, M. Kunze, K. Ramskogler, 2004, Neuropsychobiology.

Flupenthixol versus Risperidone: Subjective Quality of Life as an Important Factor for Compliance in Chronic Schizophrenic Patients

G. Saletu-Zyhlarz, K. Ramskogler, M. Beneke, 2003, Neuropsychobiology.

Alcoholism, craving, and hormones: the role of leptin, ghrelin, prolactin, and the pro-opiomelanocortin system in modulating ethanol intake.

F. Wurst, K. Junghanns, J. Kornhuber, 2007, Alcoholism, clinical and experimental research.

The European Acamprosate Trials: Conclusions for Research and Therapy

K. Ramskogler, O. Lesch, H. Walter, 2001, Journal of Biomedical Science.

Epidemiology of substance use in a representative sample of 18-year-old males.

N. Kapusta, K. Ramskogler, O. Lesch, 2006, Alcohol and alcoholism.

World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence: back to the future.

J. Whitfield, F. Wurst, H. Ko, 2005, Alcoholism, clinical and experimental research.

Sensitivity and specificity of carbohydrate-deficient transferrin in drinking experiments and different patients.

K. Ramskogler, H Walter, O. Lesch, 2001, Alcohol.

Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials.

K. Ramskogler, O. Lesch, H. Walter, 2001, Journal of biomedical science.

CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients-preliminary results.

N. Kapusta, B. Moser, H. Ankersmit, 2004, Alcoholism, clinical and experimental research.

[Craving for alcohol and prevention of relapse].

K. Ramskogler, O. Lesch, R. Mader, 2001, Wiener klinische Wochenschrift.

[Possible interaction between ethanol and drugs and their significance for drug therapy in the elderly].

K. Ramskogler, O. Lesch, H. Walter, 2001, Wiener klinische Wochenschrift.

Dopamine and Alcohol Relapse: D1 and D2 Antagonists Increase Relapse Rates in Animal Studies and in Clinical Trials

K. Ramskogler, O. Lesch, H. Walter, 2001, Journal of Biomedical Science.

DIRECT ETHANOL METABOLITES SUCH AS ETHYL GLUCURONIDE (ETG), FATTY ACID ETHYL ESTERS (FAEES), PHOSPHATIDYL ETHANOL (PETH) AND ETHYL SULPHATE - A NEW LINE OF SENSITIVE AND SPECIFIC BIOMARKERS.

F. Wurst, S. Hartmann, C. Spies, 2004 .